These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35806183)

  • 1. Neurogranin and Neurofilament Light Chain as Preclinical Biomarkers in Scrapie.
    Betancor M; Pérez-Lázaro S; Otero A; Marín B; Martín-Burriel I; Blennow K; Badiola JJ; Zetterberg H; Bolea R
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtle Differences in Cognition in 70-Year-Olds with Elevated Cerebrospinal Fluid Neurofilament Light and Neurogranin: A H70 Cross-Sectional Study.
    Rådestig MA; Skoog J; Zetterberg H; Skillbäck T; Zettergren A; Sterner TR; Fässberg MM; Sacuiu S; Waern M; Wetterberg H; Blennow K; Skoog I; Kern S
    J Alzheimers Dis; 2023; 91(1):291-303. PubMed ID: 36617786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD.
    Blennow K; Diaz-Lucena D; Zetterberg H; Villar-Pique A; Karch A; Vidal E; Hermann P; Schmitz M; Ferrer Abizanda I; Zerr I; Llorens F
    J Neurol Neurosurg Psychiatry; 2019 Aug; 90(8):846-853. PubMed ID: 31097472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of CSF neurofilament light chain, neurogranin, and tau to MRI markers.
    Mielke MM; Przybelski SA; Lesnick TG; Kern S; Zetterberg H; Blennow K; Knopman DS; Graff-Radford J; Petersen RC; Jack CR; Vemuri P
    Alzheimers Dement; 2021 May; 17(5):801-812. PubMed ID: 33663022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofilaments in blood is a new promising preclinical biomarker for the screening of natural scrapie in sheep.
    Zetterberg H; Bozzetta E; Favole A; Corona C; Cavarretta MC; Ingravalle F; Blennow K; Pocchiari M; Meloni D
    PLoS One; 2019; 14(12):e0226697. PubMed ID: 31856243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias.
    Abu-Rumeileh S; Capellari S; Stanzani-Maserati M; Polischi B; Martinelli P; Caroppo P; Ladogana A; Parchi P
    Alzheimers Res Ther; 2018 Jan; 10(1):3. PubMed ID: 29368621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of variables associated with cerebrospinal fluid neurofilament, total-tau, and neurogranin.
    Mielke MM; Syrjanen JA; Blennow K; Zetterberg H; Skoog I; Vemuri P; Machulda MM; Graff-Radford J; Knopman DS; Jack CR; Petersen RC; Kern S
    Alzheimers Dement; 2019 Nov; 15(11):1437-1447. PubMed ID: 31668594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer's disease.
    Pereira JB; Westman E; Hansson O;
    Neurobiol Aging; 2017 Oct; 58():14-29. PubMed ID: 28692877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum.
    Bos I; Vos S; Verhey F; Scheltens P; Teunissen C; Engelborghs S; Sleegers K; Frisoni G; Blin O; Richardson JC; Bordet R; Tsolaki M; Popp J; Peyratout G; Martinez-Lage P; Tainta M; Lleó A; Johannsen P; Freund-Levi Y; Frölich L; Vandenberghe R; Westwood S; Dobricic V; Barkhof F; Legido-Quigley C; Bertram L; Lovestone S; Streffer J; Andreasson U; Blennow K; Zetterberg H; Visser PJ
    Alzheimers Dement; 2019 May; 15(5):644-654. PubMed ID: 30853464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease.
    Abu-Rumeileh S; Baiardi S; Ladogana A; Zenesini C; Bartoletti-Stella A; Poleggi A; Mammana A; Polischi B; Pocchiari M; Capellari S; Parchi P
    J Neurol Neurosurg Psychiatry; 2020 Nov; 91(11):1181-1188. PubMed ID: 32928934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal Fluid Prion Disease Biomarkers in Pre-clinical and Clinical Naturally Occurring Scrapie.
    Llorens F; Barrio T; Correia Â; Villar-Piqué A; Thüne K; Lange P; Badiola JJ; Schmitz M; Lachmann I; Bolea R; Zerr I
    Mol Neurobiol; 2018 Nov; 55(11):8586-8591. PubMed ID: 29572672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease.
    Vallabh SM; Minikel EV; Williams VJ; Carlyle BC; McManus AJ; Wennick CD; Bolling A; Trombetta BA; Urick D; Nobuhara CK; Gerber J; Duddy H; Lachmann I; Stehmann C; Collins SJ; Blennow K; Zetterberg H; Arnold SE
    BMC Med; 2020 Jun; 18(1):140. PubMed ID: 32552681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and cerebrospinal fluid brain damage markers neurofilament light and glial fibrillary acidic protein correlate with tick-borne encephalitis disease severity-a multicentre study on Lithuanian and Swedish patients.
    Veje M; Griška V; Pakalnienė J; Mickienė A; Bremell D; Zetterberg H; Blennow K; Lindquist L; Studahl M
    Eur J Neurol; 2023 Oct; 30(10):3182-3189. PubMed ID: 37431060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid neurofilament light in suspected sporadic Creutzfeldt-Jakob disease.
    Kanata E; Golanska E; Villar-Piqué A; Karsanidou A; Dafou D; Xanthopoulos K; Schmitz M; Ferrer I; Karch A; Sikorska B; Liberski PP; Sklaviadis T; Zerr I; Llorens F
    J Clin Neurosci; 2019 Feb; 60():124-127. PubMed ID: 30309804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood β-Synuclein and Neurofilament Light Chain During the Course of Prion Disease.
    Halbgebauer S; Abu-Rumeileh S; Oeckl P; Steinacker P; Roselli F; Wiesner D; Mammana A; Beekes M; Kortazar-Zubizarreta I; Perez de Nanclares G; Capellari S; Giese A; Castilla J; Ludolph AC; Žáková D; Parchi P; Otto M
    Neurology; 2022 Apr; 98(14):e1434-e1445. PubMed ID: 35110380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease.
    Mattsson N; Insel PS; Palmqvist S; Portelius E; Zetterberg H; Weiner M; Blennow K; Hansson O;
    EMBO Mol Med; 2016 Oct; 8(10):1184-1196. PubMed ID: 27534871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluid Biomarkers in Individuals at Risk for Genetic Prion Disease up to Disease Conversion.
    Vallabh SM; Mortberg MA; Allen SW; Kupferschmid AC; Kivisakk P; Hammerschlag BL; Bolling A; Trombetta BA; Devitte-McKee K; Ford AM; Sather LE; Duffy G; Rivera A; Gerber J; McManus AJ; Minikel EV; Arnold SE
    Neurology; 2024 Jul; 103(2):e209506. PubMed ID: 38896810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid biomarkers of axonal and synaptic degeneration in a population-based sample.
    Arvidsson Rådestig M; Skoog I; Skillbäck T; Zetterberg H; Kern J; Zettergren A; Andreasson U; Wetterberg H; Kern S; Blennow K
    Alzheimers Res Ther; 2023 Mar; 15(1):44. PubMed ID: 36869347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for neurodegeneration in Langerhans cell histiocytosis with neurofilament light in plasma.
    Sveijer M; von Bahr Greenwood T; Jädersten M; Kvedaraite E; Zetterberg H; Blennow K; Lourda M; Gavhed D; Henter JI
    Br J Haematol; 2022 Aug; 198(4):721-728. PubMed ID: 35582775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.
    Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K
    JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.